This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Role of Interferon- in Cutaneous Trafficking of Lymphocytes With Emphasis on Molecular and Cellular Adhesion Events

Brian J. Nickoloff, MD, PhD

Arch Dermatol. 1988;124(12):1835-1843.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Interferons (IFNs) are receiving increasing attention by dermatologists for both therapeutic applications,¹ as well as for investigations of their role as potential mediators of inflammation and cellular proliferation (an International Dermatology Symposium on "Interferons and Related Lymphokines" is planned for October 1989 in Berlin). As Shiohara et al in this issue of the ARCHIVES indicate, IFNs may be important in psoriasis.² In a previous editorial I reviewed this topic and concluded that due to the multiplicity of biologic effects of IFNs, more basic scientific knowledge was required to determine the role(s) of IFNs in skin diseases.³ One of the major new developments that was previously alluded to involves the ability of IFN- to modulate T lymphocyte trafficking in the skin.³ This editorial focuses primarily on the role of INF- in modulating the accumulation of peripheral blood monocytes and lymphocytes (PBML) in the skin, and is divided . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Pathology and Dermatology, University of Michigan Medical Center, Ann Arbor.

Footnotes
Accepted for publication June 22, 1988.

Reprint requests to Department of Pathology, University of Michigan Medical Center, M4232 Medical Science 1,1301 Catherine Rd, Ann Arbor, MI 48109-0602 (Dr Nickoloff).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?